SLU-PP-332 250MCG /ORFORGLIPRON 6MG 60 CAPSULES
SKU: ORAL_CP_SLU_PP_332_ORFORGLIPRON_250MCG_6MG_CAP
Catalog price · 1 item: US$160.00 (USD)
Product information
ERR pathway context
The page's narrative focuses on SLU-PP-332 as an activator of ERRα, ERRβ and ERRγ, orphan nuclear receptors involved in metabolic gene regulation. It refers to nonclinical investigations of ERR-dependent pathways; it does not supply a separate narrative or combined-effect study for the orforglipron component.
Specifications
| SKU | ORAL_CP_SLU_PP_332_ORFORGLIPRON_250MCG_6MG_CAP |
|---|---|
| CATEGORY | Peptide Capsules |
| CAS | SLU-PP-332: 303760-60-3 Orforglipron: 2212020-52-3 |
| PACKAGE SIZE | 60 capsules per unit |
| FORM | Encapsulated compound |
| MOLECULAR WEIGHT | N/A |
| COMPOSITION | SLU-PP-332 250 mcg Orforglipron 6 mg per capsule |
| MOLECULAR FORMULA | N/A |
| ITEM ID | 29911 |
| FORM | Encapsulated compound |
| CAS | 303760-60-3 |
| Formula | C18H14N2O2 |
| Mol. Wt. | 290.32 g/mol |
| Sequence | N/A |
| CAS | 2212020-52-3 |
| Formula | C48H48F2N20O5 |
| Mol. Wt. | 882.96 g/mol |
| Sequence | N/A |